2022
DOI: 10.1016/j.neurom.2022.01.023
|View full text |Cite
|
Sign up to set email alerts
|

Spinal Cord Stimulation in the Treatment of Cancer Pain: A Retrospective Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…18 SCS acts on multiple pathways in the central nervous system and is therefore used to treat a variety of other conditions such as angina pectoris, ischemic pain due to peripheral vascular disease, occipital neuralgia, peripheral neuropathy, postherpetic neuralgia, and visceral pain such as interstitial cystitis, pancreatitis, and cancer pain. [19][20][21][22][23][24][25][26] The findings of previous studies indicated that SCS was effective in improving quality of life, decreasing pain visual analog score, improving lower limb blood flow, increasing lower limb skin temperature, and decreasing amputation rates in patients with mixed diabetic foot and peripheral neuropathy. 27,28 SCS was superior to endovascular intervention in the treatment of painful DFU.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…18 SCS acts on multiple pathways in the central nervous system and is therefore used to treat a variety of other conditions such as angina pectoris, ischemic pain due to peripheral vascular disease, occipital neuralgia, peripheral neuropathy, postherpetic neuralgia, and visceral pain such as interstitial cystitis, pancreatitis, and cancer pain. [19][20][21][22][23][24][25][26] The findings of previous studies indicated that SCS was effective in improving quality of life, decreasing pain visual analog score, improving lower limb blood flow, increasing lower limb skin temperature, and decreasing amputation rates in patients with mixed diabetic foot and peripheral neuropathy. 27,28 SCS was superior to endovascular intervention in the treatment of painful DFU.…”
mentioning
confidence: 99%
“…18 SCS acts on multiple pathways in the central nervous system and is therefore used to treat a variety of other conditions such as angina pectoris, ischemic pain due to peripheral vascular disease, occipital neuralgia, peripheral neuropathy, postherpetic neuralgia, and visceral pain such as interstitial cystitis, pancreatitis, and cancer pain. 19-26…”
mentioning
confidence: 99%